Source:http://linkedlifedata.com/resource/pubmed/id/20024841
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2009-12-21
|
pubmed:abstractText |
The Ion Channels as Therapeutic Targets meeting, held in Boston, included topics covering new therapeutic developments in the field of ion-channel drug discovery. This conference report highlights selected presentations on sensory transient receptor potential channels, potassium-channel modulation, as well as methods for chloride-channel screening and channel occupancy evaluation. Human genetic mutations observed in channelopathies and methods to predict the cardiovascular safety of ion-channel modulators were also discussed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
2040-3410
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
16-9
|
pubmed:meshHeading |
pubmed-meshheading:20024841-Animals,
pubmed-meshheading:20024841-Channelopathies,
pubmed-meshheading:20024841-Chloride Channels,
pubmed-meshheading:20024841-Drug Delivery Systems,
pubmed-meshheading:20024841-Drug Design,
pubmed-meshheading:20024841-Humans,
pubmed-meshheading:20024841-Ion Channels,
pubmed-meshheading:20024841-Mutation,
pubmed-meshheading:20024841-Potassium Channels,
pubmed-meshheading:20024841-Transient Receptor Potential Channels
|
pubmed:year |
2010
|
pubmed:articleTitle |
Ion Channels as Therapeutic Targets--CHI's Fourth Annual Conference.
|
pubmed:affiliation |
GlaxoSmithKline plc, 709 Swedeland Road, King of Prussia, PA 19406, USA. kevin.s.thorneloe@gsk.com
|
pubmed:publicationType |
Journal Article
|